The National Institute for Health and Care Excellence (NICE) has recommended the use of the drug selpercatinib (Retevmo) for some people in England with a type of advanced thyroid cancer.
Three thyroid cancer treatments have been approved for routine use on the NHS in England.
The results of a large Cancer Research UK trial have set a new gold standard for treating thyroid cancer, reducing radiation doses to just one third of the current level, according to research in The New England Journal of Medicine.
Courageous cancer Survivor Findlay Young is half way through his mission to run 24 half marathons in 24 consecutive days in 24 different locations in 12 countries and six continents around the world for Cancer Research UK.
A courageous cancer survivor jogged alone across the Tyne Bridge at 6.00am on Thursday, September 7th to highlight the start of his fundraising mission to run 24 half marathons in 24 consecutive days, ending with the BUPA Great North Run. Findlay Young, 32, aims to raise Ј100,000 for Cancer Research UK after surviving thyroid cancer twice in two years.